Sionna Therapeutics, Inc.
- SION
- NASDAQ
- Biotechnology
- Cystic Fibrosis Drugs
- CFTR Modulators
$3.89
Today −4.66%Quote Oct 16, 2026, 08:00 PM UTC
−45.82%over the last month
Max drawdown −45.8%From 1-month high −45.8%3 months −91.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$175.6M
Quote Oct 16
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$27.40
+604.4% from here
Floor
—
Data unavailable
Where the price sits
8 analysts
Analyst range, low to high
$5.00$60.00
- Price $3.89
- Resistance $3.97
- Consensus $27.40
The price is right under resistance. Analysts' average target sits about 604% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about SIONPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
59
Founded
2019